Avanos Medical, Inc. - Laporan Laba Rugi (TTM)

Avanos Medical, Inc.
DE ˙ DB ˙ US05350V1061
€ 10.80 ↑0.30 (2.86%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Avanos Medical, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 720 715 715 738 736 587 723 708 696 684 684 683 682 673 680 682 682 688 689 692
Change (%) -0.67 0.04 3.17 -0.22 -20.27 23.20 -2.14 -1.67 -1.70 0.00 -0.22 -0.15 -1.22 1.01 0.34 -0.13 0.92 0.20 0.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 314 344 350 376 384 288 356 324 302 290 288 290 294 294 297 302 303 306 313 320
Change (%) 9.35 1.63 7.61 2.18 -25.11 23.63 -8.83 -6.81 -4.10 -0.66 0.80 1.27 -0.14 1.16 1.52 0.56 1.09 2.09 2.17
% of Revenue 43.70 48.11 48.87 50.98 52.20 49.03 49.20 45.84 43.44 42.38 42.10 42.53 43.13 43.61 43.67 44.18 44.49 44.56 45.40 46.17
Gross Operating Profit 405 371 366 362 352 299 367 383 394 394 396 392 388 380 383 381 378 381 376 373
Change (%) -8.44 -1.43 -1.07 -2.71 -14.98 22.79 4.33 2.69 0.15 0.48 -0.96 -1.20 -2.04 0.90 -0.57 -0.68 0.79 -1.31 -0.93
% of Revenue 56.30 51.89 51.13 49.02 47.80 50.97 50.80 54.16 56.56 57.62 57.90 57.47 56.87 56.39 56.33 55.82 55.51 55.44 54.60 53.83
SG&A 354 327 334 334 326 257 326 332 332 326 336 346 326 321 315 304 319 321 314 316
Change (%) -7.62 2.11 -0.06 -2.22 -21.23 26.59 2.00 0.09 -1.77 2.97 2.91 -5.92 -1.26 -1.93 -3.52 4.93 0.63 -2.15 0.51
% of Revenue 49.22 45.78 46.72 45.26 44.35 43.82 45.02 46.93 47.77 47.73 49.14 50.69 47.76 47.74 46.35 44.56 46.82 46.69 45.59 45.60
R&D 16 35 9 10 10 31 16 16 15 29 15 14 13 13 12 12 13 12 11 10
Change (%) 115.43 -73.64 3.26 2.11 215.46 -46.08 -2.42 -8.07 97.30 -48.63 -5.33 -7.04 -4.55 -3.97 -4.13 9.48 -2.36 -12.90 -4.63
% of Revenue 2.25 4.88 1.29 1.29 1.32 5.21 2.28 2.27 2.13 4.27 2.19 2.08 1.94 1.87 1.78 1.70 1.86 1.80 1.57 1.49
OpEx 668 710 698 728 726 583 704 673 655 649 645 657 635 631 627 622 638 643 639 647
Change (%) 6.43 -1.76 4.27 -0.25 -19.70 20.83 -4.43 -2.73 -0.93 -0.51 1.81 -3.29 -0.71 -0.68 -0.81 2.61 0.83 -0.61 1.17
% of Revenue 92.76 99.38 97.59 98.63 98.60 99.30 97.39 95.11 94.08 94.81 94.33 96.25 93.22 93.70 92.13 91.08 93.57 93.49 92.73 93.37
Operating Income 52 4 17 10 10 4 19 35 41 36 39 26 46 42 54 61 44 45 50 46
Change (%) -91.55 290.91 -41.28 1.98 -60.19 360.98 83.07 19.08 -13.83 9.30 -34.02 80.47 -8.23 26.18 13.83 -28.08 2.28 11.83 -8.38
% of Revenue 7.24 0.62 2.41 1.37 1.40 0.70 2.61 4.89 5.92 5.19 5.67 3.75 6.78 6.30 7.87 8.92 6.43 6.51 7.27 6.63
Interest Expense -17 -16 -12 -9 -5 -3 -4 -6 -8 -10 -12 -13 -15 -15 -15 -14 -13 -12 -11 -10
Change (%) -9.30 -22.44 -28.10 -39.08 -37.74 15.15 47.37 37.50 29.87 22.00 6.56 13.08 2.04 -2.67 -2.74 -10.56 -3.94 -8.20 -9.82
% of Revenue -2.39 -2.18 -1.69 -1.18 -0.72 -0.56 -0.53 -0.79 -1.11 -1.46 -1.78 -1.90 -2.16 -2.23 -2.15 -2.08 -1.86 -1.77 -1.63 -1.46
Net Income 14 -29 -38 2 -52 6 19 -6 45 50 45 -36 -55 -62 -62 8 16 -392 -385 -463
Change (%) -308.63 32.76 -106.23 -2,283.33 -112.02 206.35 -131.61 -839.34 11.97 -11.68 -180.72 53.89 11.55 0.65 -112.38 103.90 -2,597.45 -1.91 20.44
% of Revenue 1.93 -4.06 -5.38 0.33 -7.12 1.07 2.67 -0.86 6.48 7.38 6.52 -5.27 -8.13 -9.18 -9.15 1.13 2.30 -57.01 -55.80 -66.89

Source: Capital IQ

Other Listings
US:AVNS US$ 12.72
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista